[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342713-105":59,"doc-detail-342713-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","microbiome-bacterial-influencers-of-host-immunity-and-response-to-immunotherapy","Microbiome bacterial influencers of host immunity and response to immunotherapy","","The review explains how gut microbiota shape anti-tumor immunity and influence patient responses to immune checkpoint inhibitors (ICIs). It highlights microbiome features as potential predictive or prognostic biomarkers and describes microbiome-based adjuvant strategies that may improve clinical outcomes across diverse cancers. Specific gut-resident bacteria are discussed as drivers of immunotherapy effectiveness, while key mechanistic details linking these microbes to host immune activation remain incompletely understood.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/microbiome-bacterial-influencers-of-host-immunity-and-response-to-immunotherapy/342713/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/microbiome-bacterial-influencers-of-host-immunity-and-response-to-immunotherapy/342713.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How does the gut microbiota affect anti-tumor immunity and ICIs?","Question",{"text":113,"@type":114},"The gut microbiota can regulate local and systemic immune responses, which can either induce or inhibit response to immune checkpoint inhibitors. Microbiome features are therefore studied as predictive/prognostic biomarkers.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Why are microbiome interventions considered attractive alongside ICIs?",{"text":118,"@type":114},"Targeting the gut microbiome through different therapeutic approaches has shown potential to enhance the effectiveness of ICIs, leading to improved clinical responses in patients with a range of cancers.",{"name":120,"@type":111,"acceptedAnswer":121},"What is still unclear about how gut bacteria influence immunotherapy?",{"text":122,"@type":114},"While specific gut-resident bacteria can affect the effectiveness of immunotherapy, the detailed mechanisms by which these bacteria modulate anti-tumor immunity and ICI response are not fully understood.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},342713,1790138728,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","ll  \nOPEN ACCESS  \nReview  \nMicrobiome bacterial inﬂuencers of host immunity and response to immunotherapy  \nYeganeh Youseﬁ,1 Kelly J. Baines,1,2 and Saman Maleki Vareki1,2,3,*  \n1Verspeeten Family Cancer Centre, Lawson Health Research Institute, London, ON N6A 5W9, Canada  \n2Department of Pathology and Laboratory Medicine, Western University, London, ON N6A 3K7, Canada  \n3Department of Oncology, Western University, London, ON N6A 3K7, Canada  \n*Correspondence: [saman.malekivareki@lhsc.on.ca](saman.malekivareki@lhsc.on.ca)[ ](saman.malekivareki@lhsc.on.ca)[https://doi.org/10.1016/j.xcrm.2024.101487](https://doi.org/10.1016/j.xcrm.2024.101487)  \nSUMMARY  \nThe gut microbiota inﬂuences anti-tumor immunity and can induce or inhibit response to immune checkpoint inhibitors (ICIs) . Therefore, microbiome features are being studied as predictive/prognostic biomarkers of patient response to ICIs, and microbiome-based interventions are attractive adjuvant treatments in combination with ICIs. Speciﬁc gut-resident bacteria can inﬂuence the effectiveness of immunotherapy; however, the mechanism of action on how these bacteria affect anti-tumor immunity and response to ICIs is not fully understood. Nevertheless, early bacterial-based therapeutic strategies have demonstrated that targeting the gut microbiome through various methods can enhance the effectiveness of ICIs, resulting in improved clinical responses in patients with a diverse range of cancers. Therefore, understanding the microbiota-driven mechanisms of response to immunotherapy can augment the success of these interventions, particularly in patients with treatment-refractory cancers.  \nINTRODUCTION  \nDifferent human tissues, such as the gastrointestinal (GI) tract, lung, and skin, are habitats for numerous microorganisms (bacteria, viruses, fungi, protozoa, and archaea), with most organs having distinct microbial communities.1 ,2 The GI tract is predominantly populated by aerobic and anaerobic bacteria.3 ,4 While the composition and functionality of the microbiome varies among individuals, these microorganisms usually have a symbiotic relationship with their hosts that beneﬁts both entities.3–5 For example, resident bacteria beneﬁt from the protected and nutrient-rich environment in the gut.6 In return, the gut microbiota is engaged in various host physiological processes such as nutrient digestion and absorption,7 ,8 vitamin synthesis,9 and prevention of pathological colonization of the gut.10 More importantly, the host immune system relies on the gut microbiota for normal development and maintaining intestinal homeostasis.4 , 11 Therefore, gut microbiota dysbiosis, disrupting homeostatic microbiota-host interactions, is associated with various diseases, such as allergy,12 obesity,13–15 diabetes,16–18 inﬂammatory bowel disease,19 and cancer.20–22  \nThe gut microbiota can impact carcinogenesis by disrupting signaling pathways involved in inﬂammation, DNA repair, and stability.23 Depending on the organ, bacterial-driven carcinogenesis is either caused by organ-speciﬁc microbiota or by effects of a distant bacterial community.24 For instance, Helicobacter pylori, which infects almost half of the world’s population, has a signiﬁcant role in the onset of atrophic gastritis and the development of gastric cancer.25 On the other hand, several organs, such as the liver and pancreas, lack a recog-  \nnized microbial community; therefore, exposure to bacterial components or metabolites can contribute to carcinogenesisin these organs.23 In contrast, bacteria can have anti-tumor effects through bacterial-derived ligands that bind to toll-like receptors (TLRs) and NOD-like receptors (NLRs) on various immune cells responsible for triggering innate immunity and, asa result, promoting anti-tumor immune responses.23 ,26 ,27 Immune mediators such as type I interferons (IFNs) are produced upon activation of TLRs and NLRs, redirecting tolerogenic immune responses toward anti-tumor immunity.26 ,28 TL","cbCaic1MCoPKT84d","https://ap.wps.com/l/cbCaic1MCoPKT84d","pdf",3622224,15,"English","# Summary\n# Introduction\n## Microbiome roles in host physiology and immune homeostasis\n## Microbiota-driven links to inflammation, DNA repair, and cancer\n## Bacterial ligands and innate immune activation\n## Front-line cancer therapies and the role of ICIs","[{\"question\":\"How does the gut microbiota affect anti-tumor immunity and ICIs?\",\"answer\":\"The gut microbiota can regulate local and systemic immune responses, which can either induce or inhibit response to immune checkpoint inhibitors. Microbiome features are therefore studied as predictive/prognostic biomarkers.\"},{\"question\":\"Why are microbiome interventions considered attractive alongside ICIs?\",\"answer\":\"Targeting the gut microbiome through different therapeutic approaches has shown potential to enhance the effectiveness of ICIs, leading to improved clinical responses in patients with a range of cancers.\"},{\"question\":\"What is still unclear about how gut bacteria influence immunotherapy?\",\"answer\":\"While specific gut-resident bacteria can affect the effectiveness of immunotherapy, the detailed mechanisms by which these bacteria modulate anti-tumor immunity and ICI response are not fully understood.\"}]","Microbiome bacterial influencers of host immunity and response to immunotherapy | PDF",1790047816,38,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e15668c1df8999d99af217a1f534d5f8.webp",983,1276,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aad79e5e70c069d20ec050cdbfc790b0.webp",982,1275,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3857e34b25be5d9b9e95c973ef14433c.webp",981,755,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/afc93e85f7170124366b2ca3e63f7b4f.webp",980,1272]